SANF

Sanofi News

Best deals to access real time data!
Real-time Level 1 for Borsa Italiana
Monthly Subscription
for only
$14.77
Italian Stock Exchange Level 2
Monthly Subscription
for only
$23.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Sanofi SANF Italy Ordinary Share
  Price Change Change Percent Stock Price Last Traded
-0.58 -0.56% 103.60 11:29:59
Open Price Low Price High Price Close Price Prev Close
103.50 103.50 103.60 103.60 104.18
more quote information »

Recent News

Date Time Source Heading
5/26/202210:07IHNWFeaturedEmerging Markets Report: A Case for Uranium
5/26/20229:07IHNWFeaturedGrove Inc. Upexi Division Launches Medicinal Mushroom Product Line Direct to Consumer and on Amazon
5/26/20228:35IHNWFeaturedSciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
5/20/202215:15GLOBEPress Release: FDA approves Dupixent® (dupilumab) as first..
5/15/202203:30GLOBEPress Release: Sarclisa® (isatuximab) combination provides..
5/11/202202:00GLOBEPress Release: New nirsevimab data analyses reinforce..
5/04/202206:00GLOBECommuniqué de presse : Foundation S, nouveau fer de lance du..
5/03/202213:00GLOBECommuniqué de presse : Assemblée Générale Annuelle du 3 mai..
4/28/202201:30GLOBECommuniqué de presse : Poursuite de la forte hausse du BNPA..
4/26/202214:28GLOBESanofi: Informations relatives au nombre de droits de vote..
4/26/202206:47GLOBECommuniqué de presse : Sanofi s’associe à McLaren Racing..
4/14/202201:00GLOBEPress Release: Positive Phase 1/2 study results of..
4/12/202212:25GLOBESanofi - AGM 03.05.2022 - Mise à disposition des documents..
4/07/202201:00GLOBECommuniqué de presse: La Commission européenne approuve..
4/04/202206:00GLOBECommuniqué de presse : Sanofi crée un Conseil Diversité,..
4/04/202201:00GLOBECommuniqué de presse: La FDA accepte d’accorder un examen..
4/01/202201:30GLOBECommuniqué de presse : Cotation d’EUROAPI sur Euronext Paris..
3/31/202201:00GLOBEPress Release: Sanofi successfully priced an inaugural..
3/30/202201:30GLOBECommuniqué de presse : Mise en ligne du document «Q1 2022..
3/29/202201:00GLOBECommuniqué de presse: Sanofi et IGM Biosciences annoncent un..
3/28/202221:00GLOBECommuniqué de presse: Sanofi poursuit sa trajectoire de..
3/28/202203:00GLOBEPress Release: Xenpozyme® (olipudase alfa) approved in..
3/26/202212:45GLOBESanofi: Information concerning the total number of voting..
3/26/202210:00GLOBECommuniqué de presse: Des données de phase III de dernière..
3/18/202207:48GLOBECommuniqué de presse : Sanofi lance le projet de cotation..
3/16/202206:18GLOBEPress Release: Sanofi and Seagen announce collaboration to..
3/15/202202:00GLOBESanofi annonce une collaboration de 300 millions d’euros..
3/14/202202:00GLOBESanofi fait le point sur l’étude de phase II évaluant..
3/09/202201:00GLOBEL’étude pivot consacrée à l’efanesoctocog alpha a atteint..
3/08/202208:25GLOBESanofi recognized by S&P as one of the most..
3/03/202202:00GLOBELe nirsevimab protège significativement les nourrissons..
2/26/202212:05GLOBEDes données de phase III de dernière minute présentées au..
2/26/202212:00GLOBEDes données de phase III de dernière minute présentées au..
2/23/202214:16GLOBEFiling of the 2021 U.S. Form 20-F and French “Document..
2/23/202205:19GLOBESanofi et GSK vont demander l’approbation réglementaire de..
2/23/202205:15GLOBESanofi and GSK to seek regulatory authorization for COVID-19..
2/22/202213:14GLOBESanofi: Informations relatives au nombre de droits de vote..
2/22/202212:32GLOBESanofi’s Board of Directors proposes the appointment of..
2/18/202201:00GLOBEPoint d’actualité sur le programme de phase III relatif à..
2/10/202201:00GLOBEFDA accepts Dupixent® (dupilumab) for Priority Review in..
2/09/202212:00GLOBEL’olipudase alpha permet d’obtenir des améliorations..
2/04/202217:00GLOBELa FDA approuve Enjaymo™ (sutimlimab-jome), le premier..
2/04/202201:30GLOBEPress Release: Strong 2021 sales and business EPS growth..
2/03/202211:00GLOBECommuniqué de presse : Sanofi dévoile sa nouvelle marque et..
1/31/202201:00GLOBELe CHMP recommande l’approbation de Dupixent® (dupilumab)..
1/19/202201:00GLOBESecond positive Phase 3 Dupixent® (dupilumab) trial confirms..
1/17/202213:14GLOBESanofi: Information concerning the total number of voting..
1/07/202201:00GLOBEExscientia and Sanofi establish strategic research..
1/04/202201:30GLOBEMise en ligne du document «Q4 2021 Memorandum for modelling..
12/21/202115:52GLOBESanofi: Information concerning the total number of voting..
12/20/202123:30GLOBESanofi to acquire Amunix immuno-oncology pipeline with next..
12/16/202102:00GLOBEPress Release: Gilles SCHNEPP takes over as Chairman of the..
12/15/202101:30GLOBESanofi and GSK announce positive preliminary booster data..


Your Recent History
BIT
SANF
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.